자매에서 발생한 중증 마이코플라즈마 폐렴에서 스테로이드 치료
Corticosteroid Treatment in Siblings Affected with Severe Mycoplasma pneumoniae Pneumonia
0
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Numerous evidences support the pathogenesis that M. pneumoniae pneumonia is associated with cell-mediated immune reaction. We report 2 cases of severe M. pneumoniae pneumonia in previously healthy sisters, who were both admitted during an epidemic of M.pneumoniae pneumonia. The elder sister, who was 16 years old, was admitted with M. pneumoniae pneumonia. She showed no response to treatment with clarithromycin and levofloxacin, and eventually progressed to severe ARDS, requiring mechanical ventilation. After treatment with hydrocortisone (200 mg/day), there were rapid improvements in clinical manifestations and chest radiographic findings. The younger sister, who was 14 years old, was admitted 10 days later, presenting with fever but no pneumonic lesions on chest radiograph. Just like her sister, the infection showed no response to clarithromycin. Fever persisted and pneumonic consolidation with mild pleural effusion was noticed in the left lower lobe on the 5th hospital-day. After treatment with oral prednisolone (1 mg/kg), she showed rapid defervescence and on the 8th hospital day, no pneumonic lesions were detectable on chest radiograph. Given the fact that the pathogenesis of pneumonia and extrapulmonary manifestations in M. pneumoniae infection is immune-mediated, an immunosuppressive therapy would be validated for selected patients with M. pneumoniae infections.
Abstract
Numerous evidences support the pathogenesis that M. pneumoniae pneumonia is associated with cell-mediated immune reaction. We report 2 cases of severe M. pneumoniae pneumonia in previously healthy sisters, who were both admitted during an epidemic of M.pneumoniae pneumonia. The elder sister, who was 16 years old, was admitted with M. pneumoniae pneumonia. She showed no response to treatment with clarithromycin and levofloxacin, and eventually progressed to severe ARDS, requiring mechanical ventilation. After treatment with hydrocortisone (200 mg/day), there were rapid improvements in clinical manifestations and chest radiographic findings. The younger sister, who was 14 years old, was admitted 10 days later, presenting with fever but no pneumonic lesions on chest radiograph. Just like her sister, the infection showed no response to clarithromycin. Fever persisted and pneumonic consolidation with mild pleural effusion was noticed in the left lower lobe on the 5th hospital-day. After treatment with oral prednisolone (1 mg/kg), she showed rapid defervescence and on the 8th hospital day, no pneumonic lesions were detectable on chest radiograph. Given the fact that the pathogenesis of pneumonia and extrapulmonary manifestations in M. pneumoniae infection is immune-mediated, an immunosuppressive therapy would be validated for selected patients with M. pneumoniae infections.
참고문헌 (20)
- Waites KB, "Mycoplasma pneumoniae and its role as a human pathogen", Clin Microbiol Rev, 17, pp.697~728 (2004)
- Dorigo-Zetsma JW, "Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs", J Infect Dis, 183, pp.675~678 (2001)
- Chan ED, "Fulminant Mycoplasma pneumoniae pneumonia", West J Med, 162, pp.133~142 (1995)
- Radisic M, "Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment", Clin Infect Dis, 31, pp.1507~1511 (2000)
- Miyashita N, "Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit", J Med Microbiol, 56, pp.1625~1629 (2007)
- Lee KY, "Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children", Pediatr Pulmonol, 41, pp.263~268 (2006)
- Tamura A, "Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children", J Infect, 57, pp.223~228 (2008)
- Lee KY, "Pediatric respiratory infections by Mycoplasma pneumoniae", Expert Rev AntiInfect Ther, 6, pp.509~521 (2008)
- Kang KS, "Pattern of occurrence of Mycoplasma pneumoniae pneumonia in admitted children: sourthen central Korea, from 1989 to 2002", J Korean Pediatr Soc, 46, pp.474~479 (2003)
- 이승현, "마이코플라즈마 폐렴의 임상 역학적 연구(1993-2003년)", Korean Journal of Pediatrics, 48(2), pp.154~157 (2005), 대한소아과학회
- Layani-Milon MP, "Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhne-Alpes, France, during five successive winter periods", J Clin Microbiol, 37, pp.1721~1726 (1999)
- Klement E, "Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respitatory track disease", Clin Infect Dis, 43, pp.1239~1245 (2006)
- Cunha BA, "The clinical diagnosis of Mycoplasma pneumoniae: the diagnostic importance of highly elevated serum cold agglutinins", Eur J Clin Microbiol Infect Dis, 27, pp.1017~1019 (2008)
- Loens K, "Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections", J Clin Microbiol, 41, pp.4915~4923 (2003)
- McCracken GH Jr, "Current status of antibiotic treatment for Mycoplasma pneumoniae infections", Pediatr Infect Dis, 5, pp.167~171 (1986)
- Sabato AR, "Transitory depression of immune function following Mycoplasma pneumoniae infection in children", Pediatr Res, 15, pp.813~816 (1981)
- Starr S, "Effects of measles, gamma- globulin-modified measles and vaccine measles on the tuberculin test", N Engl J Med, 270, pp.386~391 (1964)
- Tagliabue C, "The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae infection", J Infect Dis, 198, pp.1180~1188 (2008)
- Tai DY, "Pharmacologic treatment of SARS: current knowledge and recommendations", Ann Acad Med Singapore, 36, pp.438~443 (2007)
- McGowan JE Jr, "Guidelines for the use of systemic glucocorticosteroids in the management of selected infections", Working group on steroid use, antimicrobial agents